Search Results - "LOPRESTI, Brian J"

Refine Results
  1. 1

    Molecular imaging of microglia/macrophages in the brain by Venneti, Sriram, Lopresti, Brian J., Wiley, Clayton A.

    Published in Glia (01-01-2013)
    “…Neuroinflammation perpetuates neuronal damage in many neurological disorders. Activation of resident microglia and infiltration of monocytes/macrophages…”
    Get full text
    Journal Article
  2. 2

    The peripheral benzodiazepine receptor (Translocator protein 18kDa) in microglia: from pathology to imaging by Venneti, Sriram, Lopresti, Brian J, Wiley, Clayton A

    Published in Progress in neurobiology (01-12-2006)
    “…Microglia constitute the primary resident immune surveillance cell in the brain and are thought to play a significant role in the pathogenesis of several…”
    Get full text
    Journal Article
  3. 3

    Validation of amyloid PET positivity thresholds in centiloids: a multisite PET study approach by Royse, Sarah K, Minhas, Davneet S, Lopresti, Brian J, Murphy, Alice, Ward, Tyler, Koeppe, Robert A, Bullich, Santiago, DeSanti, Susan, Jagust, William J, Landau, Susan M

    Published in Alzheimer's research & therapy (10-05-2021)
    “…Inconsistent positivity thresholds, image analysis pipelines, and quantitative outcomes are key challenges of multisite studies using more than one β-amyloid…”
    Get full text
    Journal Article
  4. 4

    Effects of soy isoflavones on cognitive function: a systematic review and meta-analysis of randomized controlled trials by Cui, Chendi, Birru, Rahel L, Snitz, Beth E, Ihara, Masafumi, Kakuta, Chikage, Lopresti, Brian J, Aizenstein, Howard J, Lopez, Oscar L, Mathis, Chester A, Miyamoto, Yoshihiro, Kuller, Lewis H, Sekikawa, Akira

    Published in Nutrition reviews (01-02-2020)
    “…Abstract Context The results of preclinical and observational studies support the beneficial effect of soy isoflavones on cognition. Objective This review…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Radiologic Responses in Cynomolgus Macaques for Assessing Tuberculosis Chemotherapy Regimens by LING LIN, Philana, COLEMAN, Teresa, KLEIN, Edwin, BARRY, Clifton E, FLYNN, Joanne L, CARNEY, Jonathan P. J, LOPRESTI, Brian J, TOMKO, Jaime, FILLMORE, Dan, DARTOIS, Veronique, SCANGA, Charles, FRYE, L. James, JANSSEN, Christopher

    Published in Antimicrobial Agents and Chemotherapy (01-09-2013)
    “…Classifications Services AAC Citing Articles Google Scholar PubMed Related Content Social Bookmarking CiteULike Delicious Digg Facebook Google+ Mendeley Reddit…”
    Get full text
    Journal Article
  7. 7

    Development of Positron Emission Tomography β-Amyloid Plaque Imaging Agents by Mathis, Chester A., PhD, Mason, N. Scott, PhD, Lopresti, Brian J., BS, Klunk, William E., MD, PhD

    Published in Seminars in nuclear medicine (01-11-2012)
    “…For 100 years, β-amyloid (Aβ) plaques and neurofibrillary tangles (NFTs) have been recognized as the neuropathological hallmarks of Alzheimer's disease (AD),…”
    Get full text
    Journal Article
  8. 8
  9. 9

    Relative 11C-PiB Delivery as a Proxy of Relative CBF: Quantitative Evaluation Using Single-Session 15O-Water and 11C-PiB PET by Chen, Yin J, Rosario, Bedda L, Mowrey, Wenzhu, Laymon, Charles M, Lu, Xueling, Lopez, Oscar L, Klunk, William E, Lopresti, Brian J, Mathis, Chester A, Price, Julie C

    Published in The Journal of nuclear medicine (1978) (01-08-2015)
    “…The primary goal of this study was to assess the suitability of (11)C-Pittsburgh compound B ((11)C-PiB) blood-brain barrier delivery (K1) and relative delivery…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B by Price, Julie C, Klunk, William E, Lopresti, Brian J, Lu, Xueling, Hoge, Jessica A, Ziolko, Scott K, Holt, Daniel P, Meltzer, Carolyn C, DeKosky, Steven T, Mathis, Chester A

    “…A valid quantitative imaging method for the measurement of amyloid deposition in humans could improve Alzheimer's disease (AD) diagnosis and antiamyloid…”
    Get full text
    Journal Article
  13. 13
  14. 14

    PK11195 labels activated microglia in Alzheimer's disease and in vivo in a mouse model using PET by Venneti, Sriram, Lopresti, Brian J, Wang, Guoji, Hamilton, Ronald L, Mathis, Chester A, Klunk, William E, Apte, Udayan M, Wiley, Clayton A

    Published in Neurobiology of aging (01-08-2009)
    “…Abstract Activated microglia may promote neurodegeneration in Alzheimer's disease (AD) and may also help in amyloid clearance in immunization therapies. In…”
    Get full text
    Journal Article
  15. 15

    Low thalamic activity during a digit-symbol substitution task is associated with symptoms of subjective cognitive decline by Mizuno, Akiko, Karim, Helmet Talib, Ly, Maria J, Lopresti, Brian J, Cohen, Ann D, Ali, Areej A, Mathis, Chester A, Klunk, William E, Aizenstein, Howard J, Snitz, Beth E

    Published in Frontiers in psychiatry (06-09-2023)
    “…Subjective cognitive decline (SCD) may represent the earliest preclinical stage of Alzheimer's Disease (AD) for some older adults. However, the underlying…”
    Get full text
    Journal Article
  16. 16

    Ligand-based design of [18F]OXD-2314 for PET imaging in non-Alzheimer’s disease tauopathies by Lindberg, Anton, Murrell, Emily, Tong, Junchao, Mason, N. Scott, Sohn, Daniel, Sandell, Johan, Ström, Peter, Stehouwer, Jeffrey S., Lopresti, Brian J., Viklund, Jenny, Svensson, Samuel, Mathis, Chester A., Vasdev, Neil

    Published in Nature communications (14-06-2024)
    “…Positron emission tomography (PET) imaging of tau aggregation in Alzheimer’s disease (AD) is helping to map and quantify the in vivo progression of AD…”
    Get full text
    Journal Article
  17. 17
  18. 18
  19. 19

    Evaluation of voxel-based methods for the statistical analysis of PIB PET amyloid imaging studies in Alzheimer's disease by Ziolko, Scott K., Weissfeld, Lisa A., Klunk, William E., Mathis, Chester A., Hoge, Jessica A., Lopresti, Brian J., DeKosky, Steven T., Price, Julie C.

    Published in NeuroImage (Orlando, Fla.) (15-10-2006)
    “…Deposition of amyloid plaques is believed to be a central event in the development of Alzheimer's disease (AD). The present study was undertaken to evaluate…”
    Get full text
    Journal Article
  20. 20

    Impact of amyloid imaging on drug development in Alzheimer's disease by Mathis, Chester A, Lopresti, Brian J, Klunk, William E

    Published in Nuclear medicine and biology (01-10-2007)
    “…Abstract Imaging agents capable of assessing amyloid-beta (Aβ) content in vivo in the brains of Alzheimer's disease (AD) subjects likely will be important as…”
    Get full text
    Journal Article